BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22810044)

  • 1. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.
    Lin YJ; Lin IC; Yu HR; Kuo HC; Yang KD; Chang WC; Liang CD; Liu SF; Kuo HC
    Pediatr Cardiol; 2013 Feb; 34(2):250-5. PubMed ID: 22810044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital.
    Kuo CC; Lee YS; Lin MR; Hsia SH; Chen CJ; Chiu CH; Hwang MS; Huang YC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):184-190. PubMed ID: 27591913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease.
    Liu FF; Liu HH; Qiu Z; Wang JJ; Samadli S; Wu Y; Wu YF; Xu Y; Luo HH; Chen WX; Zhang DD; Hu P
    Eur J Clin Invest; 2020 Apr; 50(4):e13210. PubMed ID: 32061097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki disease in a pediatric intensive care unit: a case-control study.
    Dominguez SR; Friedman K; Seewald R; Anderson MS; Willis L; Glodé MP
    Pediatrics; 2008 Oct; 122(4):e786-90. PubMed ID: 18809597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki Disease: Beyond IVIG and Aspirin.
    Moussa T; Wagner-Weiner L
    Pediatr Ann; 2019 Oct; 48(10):e400-e405. PubMed ID: 31609999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological involvement in Kawasaki disease: a retrospective study.
    Liu X; Zhou K; Hua Y; Wu M; Liu L; Shao S; Wang C
    Pediatr Rheumatol Online J; 2020 Jul; 18(1):61. PubMed ID: 32664982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
    Dominguez SR; Martin B; Heizer H; Jone PN; Tong S; Davidson J; Anderson MS; Glodé MP
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):297-302. PubMed ID: 26407256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
    Giannouli G; Tzoumaka-Bakoula C; Kopsidas I; Papadogeorgou P; Chrousos GP; Michos A
    Pediatr Cardiol; 2013 Aug; 34(6):1476-81. PubMed ID: 23463134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.